What is the average price target for IBOTTA INC-CL A (IBTA) stock?
14 analysts have analysed IBTA and the average price target is 28.41 USD. This implies a price decrease of -10.9% is expected in the next year compared to the current price of 31.89.
NYSE:IBTA • US4510511060
View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for IBOTTA INC-CL A (IBTA).
| Date | Firm | Action | From → To |
|---|---|---|---|
| 2026-02-26 | Wells Fargo | Maintains | Equal-Weight -> Equal-Weight |
| 2026-02-26 | Evercore ISI Group | Maintains | In-Line -> In-Line |
| 2025-11-13 | Evercore ISI Group | Maintains | In-Line -> In-Line |
| 2025-11-13 | Goldman Sachs | Maintains | Sell -> Sell |
| 2025-11-13 | B of A Securities | Maintains | Underperform -> Underperform |
| 2025-10-15 | Goldman Sachs | Downgrade | Neutral -> Sell |
| 2025-08-14 | JMP Securities | Downgrade | Market Outperform -> Market Perform |
| 2025-08-14 | UBS | Maintains | Neutral -> Neutral |
| 2025-08-14 | Needham | Maintains | Buy -> Buy |
| 2025-08-14 | Wells Fargo | Downgrade | Overweight -> Equal-Weight |
| 2025-08-14 | Evercore ISI Group | Downgrade | Outperform -> In-Line |
| 2025-08-14 | Goldman Sachs | Downgrade | Buy -> Neutral |
| 2025-08-14 | B of A Securities | Downgrade | Neutral -> Underperform |
| 2025-05-16 | Goldman Sachs | Maintains | Buy -> Buy |
| 2025-05-15 | JMP Securities | Reiterate | Market Outperform -> Market Outperform |
| 2025-05-15 | UBS | Maintains | Neutral -> Neutral |
| 2025-05-15 | Needham | Maintains | Buy -> Buy |
| 2025-05-15 | Wells Fargo | Maintains | Overweight -> Overweight |
| 2025-04-14 | Goldman Sachs | Maintains | Buy -> Buy |
| 2025-03-10 | Citizens Capital Markets | Reiterate | Market Outperform -> Market Outperform |
| 2025-02-27 | Needham | Maintains | Buy -> Buy |
| 2025-02-27 | Wells Fargo | Maintains | Overweight -> Overweight |
| 2025-02-27 | Goldman Sachs | Maintains | Buy -> Buy |
| 2025-02-27 | Citigroup | Downgrade | Buy -> Neutral |
| 2025-01-27 | JMP Securities | Reiterate | Market Outperform -> Market Outperform |
| 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | ||
|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 320.037M 51.89% | 367.254M 14.75% | 342.389M -6.77% | 349.29M 2.02% | 380.57M 8.96% | 427.99M 12.46% | |
| EBITDA YoY % growth | 62.624M 284.22% | 36.005M -42.51% | 10.179M -71.73% | 43.661M 328.93% | 56.221M 28.77% | 81.373M 44.74% | |
| EBIT YoY % growth | 55.96M 238.81% | 27.925M -50.10% | 1.859M -93.34% | -25.547M -1,474.24% | -12.408M 51.43% | 4.944M 139.85% | |
| Operating Margin | 17.49% | 7.60% | 0.54% | -7.31% | -3.26% | 1.16% | |
| EPS YoY % growth | N/A | 0.19 | 0.15 -21.05% | -0.78 -616.80% | -0.51 34.43% | 0.11 122.07% |
All data in USD
| Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | Q1 / 27 | Q2 / 27 | Q3 / 27 | Q4 / 27 | Q1 / 28 | Q2 / 28 | Q3 / 28 | Q4 / 28 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| EPS Q2Q % growth | -0.31 -622.14% | -0.25 -413.28% | -0.15 -408.92% | -0.06 -56.65% | -0.19 39.77% | -0.06 75.58% | 0.03 119.81% | 0.15 344.18% | -0.18 2.70% | 0.04 166.67% | 0.14 366.67% | 0.17 13.33% |
| Revenue Q2Q % growth | 81.663M -3.44% | 85.044M -1.14% | 87.889M 5.56% | 94.296M 6.52% | 89.287M 9.34% | 92.674M 8.97% | 97.111M 10.49% | 106.83M 13.29% | 99.093M 10.98% | 102.24M 10.32% | 104.03M 7.12% | 112.95M 5.73% |
| EBITDA Q2Q % growth | 7.327M 661.64% | 10.068M 56.14% | 11.76M 36.44% | 14.507M 110.92% | 9.389M 28.14% | 12.434M 23.50% | 15.127M 28.63% | 21.573M 48.71% | 10.873M 15.81% | 17.819M 43.31% | 21.236M 40.38% | 24.092M 11.68% |
| EBIT Q2Q % growth | -9.768M -711.99% | -8.014M -536.03% | -5.229M -289.05% | -2.506M -73.82% | -938.4K 90.39% | 2.086M 126.03% | 4.758M 190.99% | 10.894M 534.64% | 8.548M 1,010.91% | 15.422M 639.31% | 18.788M 294.87% | 21.604M 98.31% |
All data in USD
14 analysts have analysed IBTA and the average price target is 28.41 USD. This implies a price decrease of -10.9% is expected in the next year compared to the current price of 31.89.
IBOTTA INC-CL A (IBTA) will report earnings on 2026-05-06.
The consensus EPS estimate for the next earnings of IBOTTA INC-CL A (IBTA) is -0.31 USD and the consensus revenue estimate is 81.66M USD.
The consensus rating for IBOTTA INC-CL A (IBTA) is 51.4286 / 100 . This indicates that analysts generally have a neutral outlook on the stock.